Literature DB >> 24952075

Comparable constitutive expression and activity of cytochrome P450 between the lobes of the porcine liver.

Martin Krøyer Rasmussen1, Galia Zamaratskaia2, Bo Ekstrand3.   

Abstract

Due to limited availability of human liver tissue for the study of cytochrome P450 (CYP450), porcine liver tissue has been suggested as an alternative source to prepare microsomes and hepatocytes. The porcine liver is made by four different lobes. The present study investigated the expression and activity of specific CYP450 isoforms in the four lobes, with the purpose to examine if one lobe of the porcine liver resembles the human more than others. Samples from the four major lobes were taken from female pigs and mRNA expression and activity of CYP1A, 2A, 2C, 2D, 2E and 3A determined. The results showed no differences in specific mRNA expression and activity of any of the investigated CYP450 isoforms. In conclusion, the study shows that all parts of the porcine liver are equally useful as model tissue.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Detoxification; Inter-individual; Intra-hepatic; Model system; PCA; Porcine liver

Mesh:

Substances:

Year:  2014        PMID: 24952075     DOI: 10.1016/j.tiv.2014.06.002

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  3 in total

Review 1.  Porcine cytochrome P450 3A: current status on expression and regulation.

Authors:  Martin Krøyer Rasmussen
Journal:  Arch Toxicol       Date:  2020-03-14       Impact factor: 5.153

Review 2.  Regulation of porcine hepatic cytochrome p450 - implication for boar taint.

Authors:  Martin Krøyer Rasmussen; Galia Zamaratskaia
Journal:  Comput Struct Biotechnol J       Date:  2014-09-10       Impact factor: 7.271

3.  Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification.

Authors:  Kata W Pedersen; Jakob Hansen; Jørgen B Hasselstrøm; Jakob R Jornil
Journal:  Pharmacol Res Perspect       Date:  2021-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.